FDA grants traditional approval to Novartis’ Fabhalta for IgAN
The US Food and Drug Administration (FDA) has issued traditional approval to Novartis for Fabhalta (iptacopan), to slow the decline…
All articles by Salong Debbarma
Salong Debbarma
-
-
JCVI issues recommendation on adolescent MenB vaccination in UK
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.…
-
Telix opens radiopharmaceutical facility in Australia for cancer treatment
Telix Pharmaceuticals has officially opened a radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, Australia, to expedite the delivery of…
-
Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy
Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration (NMPA) for their investigational new drug (IND)…
-
FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN
The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro…
-
Innovent licenses IBI355 rights to Spero for up to $1.1bn
Innovent Biologics has agreed an exclusive licence deal worth up to $1.1bn with Spero Therapeutics, granting Spero the rights to…
-
Novartis and Chai Discovery collaborate on antibody identification
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.…
-
Cellares and Sonoma partner to automate cell therapy manufacturing
Cellares and Sonoma Biotherapeutics have entered a collaboration to automate the manufacturing of the latter’s lead cell therapy programme, SBT-77-7101,…
-
Takeda and Indonesia partner on plasma-derived therapies
Takeda and the Indonesian Government have announced a multi-phased collaboration to strengthen the country’s plasma ecosystem and expand access to…
-
FDA approves MSD’s Keytruda combinations for MIBC
The US Food and Drug Administration (FDA) has approved two of Merck & Co’s (MSD) Keytruda (pembrolizumab) and Keytruda Qlex…